GRB-IR ISOFORMS AND INSULIN SIGNALING

Project: Research project

Project Details

Description

DESCRIPTION Insulin signal transduction is a multiple-step process and defects in insulin signaling in cells might result in insulin resistance, as occurs in NIDDM. The overall goal of this proposal is to learn more about the proteins involved in insulin signal transduction and regulation, while focusing on the newly identified insulin receptor binding protein Grb-IR (for Insulin Receptor associated Growth factor receptor binding protein) and its Pleckstrin-homology (PH) domain-containing isoform Grb-IRPH. Of interest are the observations that only Grb-IRPH undergoes insulin-stimulated phosphorylation and that the expression of Grb-IR in cells inhibits insulin signaling, suggesting isoform-specific differences on insulin signal transduction. Aim 1 is to determine the roles of the Grb-IR isoforms in insulin signaling. Aim 2 is to characterize insulin-stimulated Grb-IRPH phosphorylation. Aim 3 is to identify and characterize proteins interacting with Grb-IR isoforms.
StatusFinished
Effective start/end date9/16/9711/30/08

Funding

  • National Institutes of Health: $256,960.00
  • National Institutes of Health: $256,960.00
  • National Institutes of Health
  • National Institutes of Health: $165,038.00
  • National Institutes of Health
  • National Institutes of Health: $161,757.00
  • National Institutes of Health: $274,100.00
  • National Institutes of Health: $175,089.00
  • National Institutes of Health
  • National Institutes of Health: $169,989.00
  • National Institutes of Health: $282,287.00
  • National Institutes of Health

ASJC

  • Medicine(all)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.